This disclosure relates to heterocyclics as inhibitors of HPK1, in particular relates to a compound of Formula I or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising said compound that useful for treatment of HPK1 mediated diseases and conditions such as cancer. (I)
-
Page/Page column 129
(2021/01/29)
HETEROCYCLIC AMIDE COMPOUND
Provided is a heterocyclic amide compound that may have a PRS inhibitory action and is expected to be useful as a prophylactic or therapeutic agent for PRS associated diseases and the like including cancer. A compound represented by the following formula
-
Paragraph 0321-0323
(2019/07/31)
More Articles about upstream products of 41230-59-5